Can dynamic contrast-enhanced ultrasound (DCE-US) improve diagnostic performance in endometrial cancer staging? A proof of concept.
To compare the sensitivity and specificity of conventional two-dimensional transvaginal ultrasound/power Doppler (2D-TVU/PD) alone to 2D-TVU/PD combined with dynamic contrast-enhanced ultrasound (DCE-US) in diagnosing deep myometrial invasion (MI) and cervical stromal invasion (CSI) in women with endometrial cancer (EC) and to correlate DCE-US and 2D-TVU/PD quantitative and qualitative variables to FIGO stage ≥IB and to 'high' risk cancer (stage ≥IB and/or grade 3 endometrioid and/or non-endometrioid histology). A prospective study including 101 consecutive women with biopsy-confirmed EC, undergoing expert ultrasound examination at Karolinska University Hospital, Stockholm, Sweden, a tertiary referral center. All consenting women underwent DCE-US (using a 1.5-2.5 ml intravenous bolus of Sonovue® contrast agent) and conventional 2D-TVU/PD examination. DCE-US video clips were analyzed with regard to filling pattern, wash-in pattern and wash-out pattern and semi-quantitative DCE-US parameters (wash-in slope, time-to-peak, peak intensity and area-under-the-time-intensity-curve) obtained from a time-intensity curve. The study cohort was compared to a control cohort examined with 2D-TVU/PD only, matched 3:1 on FIGO stage and grade, using cases from our center examined according to the IETA (International Endometrial Tumor Analysis) protocol. Pathological evaluation after hysterectomy served as 'gold standard'. After exclusions, 93 women remained in the study cohort and matched to 279 women in the control cohort. The prevalence of stage IA, grade 1-2 were 51% in both cohorts. The sensitivity was higher in the study cohort than in the control cohort in diagnosing both deep MI and CSI (MI: 0.74 vs. 0.62, p=0.036, CSI: 0.75 vs. 0.51, p<0.001) whereas specificity was not significantly different (MI: 0.87 vs. 0.85, CSI: 0.96 vs. 0.95). Specificity was higher in detecting 'high' risk cancer in the study cohort (0.94 vs. 0.85, p=0.024) but sensitivity did not differ. 'High' risk cancer and FIGO stage ≥IB was characterized by a 'focal' filling pattern, with wash-in 'prior' and a 'focal' wash-out pattern on subjective assessment of DCE-US. All quantitative DCE-US parameters were significantly predictive of FIGO stage ≥IB, but not to 'high' risk cancer despite a clear trend. Combining DCE-US with 2D-TVU/PD can significantly improve the detection of deep MI and CSI without increasing the false positive rate compared to using 2D-TVU alone. It can also improve the correct classification of high-risk disease mainly by increasing the specificity and thereby possibly avoid unnecessary surgeries by almost ten percent. Quantitative DCE-US parameters, as well as a 'focal' filling pattern, endometrial wash-in 'prior' to the myometrium and a 'focal' wash-out pattern, all correlate to more advanced disease. This article is protected by copyright. All rights reserved.